Criminal Code Amendment (Controlled and Border Controlled Drugs and Precursors) Regulations 2025
I, the Honourable Sam Mostyn AC, Governor‑General of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, make the following regulations.
Dated 23 January 2025
Sam Mostyn AC
Governor‑General
By Her Excellency’s Command
Mark Dreyfus KC
Attorney‑General
Contents
1 Name
2 Commencement
3 Authority
4 Schedules
Schedule 1—Amendments
Criminal Code Regulations 2019
This instrument is the Criminal Code Amendment (Controlled and Border Controlled Drugs and Precursors) Regulations 2025.
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
Commencement information | ||
Column 1 | Column 2 | Column 3 |
Provisions | Commencement | Date/Details |
1. The whole of this instrument | 1 March 2025. | 1 March 2025 |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
This instrument is made under the Criminal Code Act 1995.
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
Criminal Code Regulations 2019
1 Section 13 (after table item 1C)
Insert:
1D | Butyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate | 1.46 | 292.0 |
1E | Butyl 3‑phenyl‑2‑methyl glycidate | 3.61 | 1,194.0 |
1F | Diethyl 2‑(2‑phenylacetyl)propanedioate (DEPAPD) | 4.75 | 1,585.0 |
2 Section 13 (after table item 3)
Insert:
3A | Ethyl alpha‑phenylacetoacetate (EAPA) | 3.28 | 1,094.0 |
3B | Ethyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate | 1.3 | 261.0 |
3C | Ethyl 3‑phenyl‑2‑methyl glycidate | 3.18 | 1,051.0 |
3D | Isobutyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate | 1.46 | 292.0 |
3E | Isobutyl 3‑phenyl‑2‑methyl glycidate | 3.61 | 1,194.0 |
3F | Isopropyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate | 1.38 | 275.0 |
3G | Isopropyl 3‑phenyl‑2‑methyl glycidate | 3.39 | 1,123.0 |
3 Section 13 (after table item 6)
Insert:
6AA | 3‑(3’,4’‑Methylenedioxyphenyl)‑2‑methyl glycidic acid | 1.33 | 266.0 |
4 Section 13 (after table item 7B)
Insert:
7BA | Norfentanyl | 0.006 | 2.8 |
5 Section 13 (after table item 8)
Insert:
8AA | 3‑Phenyl‑2‑methyl glycidic acid | 4.6 | 1,531.0 |
6 Section 13 (after table item 8A)
Insert:
8B | N‑Phenyl‑4‑piperidinamine (4‑AP) | 0.008 | 3.8 |
7 Section 13 (after table item 10A)
Insert:
10B | 1‑Phenylpropan‑2‑yl 4‑methylbenzenesulfonate (para‑tosyl‑phenyl‑2‑propanol) | 2.25 | 737.0 |
10C | 4‑Piperidone | 0.008 | 3.8 |
8 Section 13 (after table item 11)
Insert:
11A | Propyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate | 1.38 | 275.0 |
11B | Propyl 3‑phenyl‑2‑methyl glycidate | 3.39 | 1,123.0 |
9 Section 13 (at the end of the table)
Add:
14 | sec‑Butyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate | 1.46 | 292.0 |
15 | sec‑Butyl 3‑phenyl‑2‑methyl glycidate | 3.61 | 1,194.0 |
16 | N‑(tert‑Butoxycarbonyl)‑4‑piperidone | 0.015 | 7.6 |
17 | tert‑Butyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate | 1.46 | 292.0 |
18 | tert‑Butyl 4‑(phenylamino)piperidine‑1‑carboxylate (1‑boc‑4‑AP) | 0.015 | 7.3 |
19 | tert‑Butyl 3‑phenyl‑2‑methyl glycidate | 3.61 | 1,194.0 |
10 Subsection 16(1) (after table item 2)
Insert:
2AA | Butyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate | 1.46 | 14.6 |
2AB | Butyl 3‑phenyl‑2‑methyl glycidate | 3.61 | 9.6 |
11 Subsection 16(1) (after table item 2B)
Insert:
2C | Diethyl 2‑(2‑phenylacetyl)propanedioate (DEPAPD) | 4.75 | 12.7 |
12 Subsection 16(1) (after table item 5)
Insert:
5A | Ethyl alpha‑phenylacetoacetate (EAPA) | 3.28 | 8.8 |
5B | Ethyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate | 1.3 | 13.0 |
5C | Ethyl 3‑phenyl‑2‑methyl glycidate | 3.18 | 8.5 |
5D | Isobutyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate | 1.46 | 14.6 |
5E | Isobutyl 3‑phenyl‑2‑methyl glycidate | 3.61 | 9.6 |
5F | Isopropyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate | 1.38 | 13.8 |
5G | Isopropyl 3‑phenyl‑2‑methyl glycidate | 3.39 | 9.1 |
13 Subsection 16(1) (after table item 7A)
Insert:
7AA | 3‑(3’,4’‑Methylenedioxyphenyl)‑2‑methyl glycidic acid | 1.33 | 13.3 |
14 Subsection 16(1) (after table item 8B)
Insert:
8BA | Norfentanyl | 0.006 | 0.006 |
15 Subsection 16(1) (after table item 9)
Insert:
9AA | 3‑Phenyl‑2‑methyl glycidic acid | 4.6 | 12.2 |
16 Subsection 16(1) (after table item 9A)
Insert:
9B | N‑Phenyl‑4‑piperidinamine (4‑AP) | 0.008 | 0.008 |
17 Subsection 16(1) (after table item 11A)
Insert:
11B | 1‑Phenylpropan‑2‑yl 4‑methylbenzenesulfonate (para‑tosyl‑phenyl‑2‑propanol) | 2.25 | 5.9 |
11C | 4‑Piperidone | 0.008 | 0.008 |
18 Subsection 16(1) (after table item 12)
Insert:
12A | Propyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate | 1.38 | 13.8 |
12B | Propyl 3‑phenyl‑2‑methyl glycidate | 3.39 | 9.1 |
19 Subsection 16(1) (at the end of the table)
Add:
15 | sec‑Butyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate | 1.46 | 14.6 |
16 | sec‑Butyl 3‑phenyl‑2‑methyl glycidate | 3.61 | 9.6 |
17 | N‑(tert‑Butoxycarbonyl)‑4‑piperidone | 0.015 | 0.015 |
18 | tert‑Butyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate | 1.46 | 14.6 |
19 | tert‑Butyl 4‑(phenylamino) piperidine‑1‑carboxylate (1‑boc‑4‑AP) | 0.015 | 0.015 |
20 | tert‑Butyl 3‑phenyl‑2‑methyl glycidate | 3.61 | 9.6 |
20 Subsection 16(2) (at the end of the table)
Add:
5 | Methylamine | 0.6 | 1.6 |
21 Clause 1 of Schedule 1 (after table item 24)
Insert:
24A | Benzoylbenzylfentanyl | 0.005 | 2.5 | 0.005 |
22 Clause 1 of Schedule 1 (after table item 25)
Insert:
25A | Benzoylfentanyl | 0.005 | 2.5 | 0.005 |
25B | Benzylfentanyl | 0.005 | 2.5 | 0.005 |
25C | Benzylfuranylfentanyl | 0.005 | 2.5 | 0.005 |
23 Clause 1 of Schedule 1 (after table item 36)
Insert:
36A | Bromazolam | 5.0 | 1,250.0 | 30.0 |
24 Clause 1 of Schedule 1 (after table item 49)
Insert:
49A | Butonitazene | 0.005 | 2.5 | 0.005 |
25 Clause 1 of Schedule 1 (table item 66)
Repeal the item, substitute:
66 | Clonitazene | 0.005 | 2.5 | 0.005 |
26 Clause 1 of Schedule 1 (after table item 70)
Insert:
70A | N‑Desethyl etonitazene | 0.005 | 2.5 | 0.005 |
70B | N‑Desethyl isotonitazene | 0.005 | 2.5 | 0.005 |
70C | N‑Desethyl protonitazene | 0.005 | 2.5 | 0.005 |
27 Clause 1 of Schedule 1 (after table item 99)
Insert:
99A | Dipentylone (N,N‑dimethylpentylone) | 0.75 | 250.0 | 0.75 |
28 Clause 1 of Schedule 1 (after table item 106)
Insert:
106A | Ethylene etonitazene | 0.005 | 2.5 | 0.005 |
106B | Ethyleneoxynitazene | 0.005 | 2.5 | 0.005 |
29 Clause 1 of Schedule 1 (after table item 109)
Insert:
109A | Etodesnitazene (etazene) | 0.005 | 2.5 | 0.005 |
30 Clause 1 of Schedule 1 (table item 110)
Repeal the item, substitute:
110 | Etonitazene | 0.005 | 2.5 | 0.005 |
31 Clause 1 of Schedule 1 (after table item 110)
Insert:
110A | Etonitazepipne (N‑piperidinyl etonitazene) | 0.005 | 2.5 | 0.005 |
110B | Etonitazepyne (N‑pyrrolidino etonitazene) | 0.005 | 2.5 | 0.005 |
32 Clause 1 of Schedule 1 (after table item 113)
Insert:
113A | Flunitazene | 0.005 | 2.5 | 0.005 |
33 Clause 1 of Schedule 1 (after table item 117)
Insert:
117A | 2‑Fluorodeschloroketamine (2‑FDCK) | 1.0 | 500.0 | 3.0 |
34 Clause 1 of Schedule 1 (after table item 123)
Insert:
123A | Furanylfentanyl | 0.005 | 2.5 | 0.005 |
35 Clause 1 of Schedule 1 (after table item 145)
Insert:
145A | Isotodesnitazene | 0.005 | 2.5 | 0.005 |
145B | Isotonitazene | 0.005 | 2.5 | 0.005 |
36 Clause 1 of Schedule 1 (after table item 176)
Insert:
176A | Methylenedioxynitazene (2‑(2‑(benzo[d] [1,3]dioxol‑5‑ylmethyl)‑5‑nitro‑1H‑benzo [d]imidazol‑1‑yl)‑N,N‑diethylethan‑1‑amine) | 0.005 | 2.5 | 0.005 |
37 Clause 1 of Schedule 1 (after table item 193)
Insert:
193A | Metodesnitazene (metazene) | 0.005 | 2.5 | 0.005 |
193B | Metonitazene | 0.005 | 2.5 | 0.005 |
38 Clause 1 of Schedule 1 (after table item 227)
Insert:
227A | 3‑Phenylpropanoylfentanyl | 0.005 | 2.5 | 0.005 |
39 Clause 1 of Schedule 1 (after table item 234)
Insert:
234A | Protonitazene | 0.005 | 2.5 | 0.005 |
234B | Protonitazepyne (N‑pyrrolidino protonitazene) | 0.005 | 2.5 | 0.005 |
40 Clause 1 of Schedule 1 (after table item 237)
Insert:
237A | Secofentanyl | 0.005 | 2.5 | 0.005 |
41 Clause 1 of Schedule 1 (after table item 241)
Insert:
241A | Thiofuranylfentanyl | 0.005 | 2.5 | 0.005 |
42 Subclause 1(1) of Schedule 2 (after table item 20)
Insert:
20A | Benzoylbenzylfentanyl | 0.005 | 0.005 |
43 Subclause 1(1) of Schedule 2 (after table item 21)
Insert:
21A | Benzoylfentanyl | 0.005 | 0.005 |
21B | Benzylfentanyl | 0.005 | 0.005 |
21C | Benzylfuranylfentanyl | 0.005 | 0.005 |
44 Subclause 1(1) of Schedule 2 (after table item 31)
Insert:
31A | Bromazolam | 5.0 | 30.0 |
45 Subclause 1(1) of Schedule 2 (after table item 34)
Insert:
34A | Butonitazene | 0.005 | 0.005 |
46 Subclause 1(1) of Schedule 2 (table item 42)
Repeal the item, substitute:
42 | Clonitazene | 0.005 | 0.005 |
47 Subclause 1(1) of Schedule 2 (after table item 46)
Insert:
46A | N‑Desethyl etonitazene | 0.005 | 0.005 |
46B | N‑Desethyl isotonitazene | 0.005 | 0.005 |
46C | N‑Desethyl protonitazene | 0.005 | 0.005 |
48 Subclause 1(1) of Schedule 2 (after table item 77)
Insert:
77A | Dipentylone (N,N‑dimethylpentylone) | 0.75 | 2.0 |
49 Subclause 1(1) of Schedule 2 (after table item 83)
Insert:
83A | Ethylene etonitazene | 0.005 | 0.005 |
83B | Ethyleneoxynitazene | 0.005 | 0.005 |
50 Subclause 1(1) of Schedule 2 (after table item 85)
Insert:
85A | Etodesnitazene (etazene) | 0.005 | 0.005 |
51 Subclause 1(1) of Schedule 2 (table item 86)
Repeal the item, substitute:
86 | Etonitazene | 0.005 | 0.005 |
52 Subclause 1(1) of Schedule 2 (after table item 86)
Insert:
86A | Etonitazepipne (N‑piperidinyl etonitazene) | 0.005 | 0.005 |
86B | Etonitazepyne (N‑pyrrolidino etonitazene) | 0.005 | 0.005 |
53 Subclause 1(1) of Schedule 2 (after table item 89)
Insert:
89A | Flunitazene | 0.005 | 0.005 |
89B | 2‑Fluorodeschloroketamine (2‑FDCK) | 1.0 | 3.0 |
54 Subclause 1(1) of Schedule 2 (after table item 92)
Insert:
92A | Furanylfentanyl | 0.005 | 0.005 |
55 Subclause 1(1) of Schedule 2 (after table item 109)
Insert:
109A | Isotodesnitazene | 0.005 | 0.005 |
109B | Isotonitazene | 0.005 | 0.005 |
56 Subclause 1(1) of Schedule 2 (after table item 134)
Insert:
134A | Methylenedioxynitazene (2‑(2‑(benzo[d] [1,3]dioxol‑5‑ylmethyl)‑5‑nitro‑1H‑benzo [d]imidazol‑1‑yl)‑N,N‑diethylethan‑1‑amine) | 0.005 | 0.005 |
57 Subclause 1(1) of Schedule 2 (after table item 149)
Insert:
149A | Metodesnitazene (metazene) | 0.005 | 0.005 |
149B | Metonitazene | 0.005 | 0.005 |
58 Subclause 1(1) of Schedule 2 (after table item 187)
Insert:
187A | 3‑Phenylpropanoylfentanyl | 0.005 | 0.005 |
59 Subclause 1(1) of Schedule 2 (after table item 194)
Insert:
194A | Protonitazene | 0.005 | 0.005 |
194B | Protonitazepyne (N‑pyrrolidino protonitazene) | 0.005 | 0.005 |
60 Subclause 1(1) of Schedule 2 (after table item 197)
Insert:
197A | Secofentanyl | 0.005 | 0.005 |
61 Subclause 1(1) of Schedule 2 (after table item 201)
Insert:
201A | Thiofuranylfentanyl | 0.005 | 0.005 |